About: Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
Creator	Dittmer, Ulf Hope, Thomas Bergsland, Emily Bodei, Lisa De Herder, Wouter Ferone, Diego Herrmann, Ken Hicks, Rodney Kunikowska, Jolanta Pavel, Marianne Reidy-Lagunes, Diane Siveke, Jens Strosberg, Jonathan
Source	Medline; PMC
abstract	covid:647dd5a07958c51cc9be961a6518905cd50f6ab1#abstract
has issue date	2020-08-01(xsd:dateTime)
bibo:doi	10.2967/jnumed.120.249136
bibo:pmid	32576637
has license	cc-by
sha1sum (hex)	647dd5a07958c51cc9be961a6518905cd50f6ab1
schema:url	https://doi.org/10.2967/jnumed.120.249136
resource representing a document's title	Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
has PubMed Central identifier	PMC7413236
has PubMed identifier	32576637
schema:publication	J Nucl Med
resource representing a document's body	covid:647dd5a07958c51cc9be961a6518905cd50f6ab1#body_text
is schema:about of	named entity 'histone' named entity 'PRRT' named entity 'Receptor' named entity 'Pandemic' named entity 'tumor' named entity 'antibodies' named entity 'PRRT' named entity 'Celgene' named entity 'PRRT' named entity 'Servier' named entity 'neuroendocrine tumor' named entity 'immunosuppressive' named entity 'everolimus' named entity 'Merck' named entity 'vasculitis' named entity 'peripheral blood lymphocyte' named entity 'lymphopenia' named entity 'Novartis' named entity 'risk factors' named entity 'PRRT' named entity 'lymphopenia' named entity 'organ damage' named entity 'Novartis' named entity 'opportunistic pathogens' named entity 'PRRT' named entity 'H2AX' named entity 'COVID-19' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'IL-2R' named entity 'COVID-19' named entity 'virus' named entity 'lymphocytes' named entity 'H2AX' named entity 'lymphopenia' named entity 'Ipsen' named entity 'CD8' named entity 'Philips' named entity 'CD8' named entity 'phosphorylated' named entity 'COVID-19' named entity 'significant impact' named entity 'risk-benefit ratio' named entity 'prognosis' named entity 'innate immunity' named entity 'nuclear medicine' named entity 'CD8' named entity 'PRRT' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'COVID-19' named entity 'macrophages' named entity 'Endocyte' named entity 'comorbidities' named entity 'risk factor' named entity 'Celgene' named entity 'immune thrombocytopenia' named entity 'PRRT' named entity 'Amgen' named entity 'natural killer cells' named entity 'morbidity' named entity 'PRRT' named entity 'Subclinical' named entity 'nuclear medicine' named entity 'CD4' named entity 'molecular marker' named entity 'radiation-induced' named entity 'COVID-19' named entity 'Novartis' named entity 'Curium' named entity 'Novartis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software